Literature DB >> 21245897

Natural killer cells: fighting viruses and much more.

Marco Colonna1, Stipan Jonjic, Carsten Watzl.   

Abstract

More than 450 immunologists recently met in Cavtat, Croatia to discuss advances in natural killer (NK) cell biology. The meeting highlighted emerging themes in NK cell responses to viruses, NK cell tolerance and potential use of NK cells in the therapy of malignancies.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21245897     DOI： 10.1038/ni0211-107

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  21 in total

1.  Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure.

Authors:  P Triggianese; C Perricone; P Conigliaro; M S Chimenti; R Perricone; C De Carolis
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-10       Impact factor: 3.219

Review 2.  Impact of dietary components on NK and Treg cell function for cancer prevention.

Authors:  Young S Kim; Thomas J Sayers; Nancy H Colburn; John A Milner; Howard A Young
Journal:  Mol Carcinog       Date:  2015-04-01       Impact factor: 4.784

3.  Receptors for non-MHC ligands contribute to uterine natural killer cell activation during pregnancy in mice.

Authors:  A M Felker; Z Chen; W G Foster; B A Croy
Journal:  Placenta       Date:  2013-06-24       Impact factor: 3.481

4.  HIV vaccine trial exploits a dual and central role for innate immunity.

Authors:  Deborah Heydenburg Fuller; Laura E Richert-Spuhler; Nichole R Klatt
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 5.  Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature.

Authors:  Mohammadreza Shaghaghi; Mona Irannejad; Hassan Abolhassani; Shohreh Shahmahmoodi; Amir Ali Hamidieh; Saeed Soleyman-Jahi; Reza Yazdani; Gholamreza Azizi; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-06-14       Impact factor: 8.317

6.  Identification of a colonial chordate histocompatibility gene.

Authors:  Ayelet Voskoboynik; Aaron M Newman; Daniel M Corey; Debashis Sahoo; Dmitry Pushkarev; Norma F Neff; Benedetto Passarelli; Winston Koh; Katherine J Ishizuka; Karla J Palmeri; Ivan K Dimov; Chen Keasar; H Christina Fan; Gary L Mantalas; Rahul Sinha; Lolita Penland; Stephen R Quake; Irving L Weissman
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

7.  Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.

Authors:  Benyamin Rosental; Michael Brusilovsky; Uzi Hadad; Dafna Oz; Michael Y Appel; Fabian Afergan; Rami Yossef; Lior Ann Rosenberg; Amir Aharoni; Adelheid Cerwenka; Kerry S Campbell; Alex Braiman; Angel Porgador
Journal:  J Immunol       Date:  2011-10-21       Impact factor: 5.422

Review 8.  NK cells: immune cross-talk and therapeutic implications.

Authors:  Anshu Malhotra; Anil Shanker
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

9.  Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.

Authors:  Nathan C Horton; Stephen O Mathew; Porunelloor A Mathew
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation.

Authors:  Todd V Brennan; Liwen Lin; Joshua D Brandstadter; Victoria R Rendell; Keith Dredge; Xiaopei Huang; Yiping Yang
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.